Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

GSK Commences Phase 2 Study for Monoclonal Antibody

April 18, 2016 8:32 am | News | Comments

The goal is to evaluate the efficacy and safety profile of the drug in patients with inflammatory hand osteoarthritis. 


Medical Pot Activists Fear Epilepsy Drug Could Undercut Them

April 18, 2016 8:28 am | by Julie Carr Smyth, Associated Press | News | Comments

An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses.


AACR: Breast Cancer Stem Cells May Reduce Diseases' Metastatic Potential

April 18, 2016 8:24 am | by University of Colorado | News | Comments

Stem-like breast cancer cells secrete molecules that allow neighboring, otherwise anchored cells to metastasize.


Top Republicans: Zika Funding Likely But Timing Uncertain

April 17, 2016 11:15 am | by Andrew Taylor, Associated Press | News | Comments

Another senior Republican said additional Zika money most likely wouldn't come before September at the earliest.


Report: First Diagnosed Case of Alzheimer's Disease in HIV-Positive Individual

April 17, 2016 10:30 am | by Georgetown University Medical Center | News | Comments

Diagnosis of dementia in older HIV-infected individuals is on the rise.

Implantable Device Targets Pancreatic Cancer

April 16, 2016 11:30 am | by Anne Trafton, MIT News Office | News | Comments

Pancreatic cancer is the third leading cause of cancer deaths in the United States.


Weighing Coffee's Health Benefits

April 15, 2016 3:02 pm | by Colorado State University | News | Comments

Chances are, you or someone you know is a coffee drinker. 


Testing Diabetes Dosage

April 15, 2016 3:02 pm | by Northwestern University | News | Comments

A recent study investigated whether a higher dose of liraglutide may lead to greater weight loss. 


Allergen Immunotherapy Poses No Infection Risk

April 15, 2016 2:49 pm | by Massachusetts General Hospital | News | Comments

The current study was prepared to provide data supporting the response to the proposed changes from several allergy and immunology specialty organizations.


Drug Discovery Spotlight: Frightening Zika Images; Valeant's Dysfunction; Reclassifying a Tumor

April 15, 2016 11:17 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads.


Poor Patient Warfarin Knowledge May Increase Side Effects Risk

April 15, 2016 10:13 am | by European Society of Cardiology | News | Comments

Patients have poor knowledge of warfarin which may increase their risk of serious side effects, according to research presented today at EuroHeartCare 2016.


Troubles Mount for Theranos, Feds Threaten Sanctions

April 15, 2016 9:55 am | by Seth Augenstein, Digital Reporter | News | Comments

Scientific and regulatory troubles continue to mount for Theranos, the much-touted blood-testing startup.


New Tests for Choosing Right Hep C Drug Could Save Money

April 15, 2016 8:52 am | by Linda A. Johnson, AP Business Writer | News | Comments

New tests designed to help doctors pick the right hepatitis C medicine for patients could mean faster cures and lower costs.


Coffee Consumption Linked to Lower Colon Cancer Risk

April 15, 2016 8:46 am | by USC | News | Comments

The indication of decreased risk was seen across all types of coffee, both caffeinated and decaffeinated.

Vitamin D Helps Reduce Childhood Allergy Rate

April 15, 2016 8:45 am | by University of Auckland | News | Comments

Vitamin D supplements during pregnancy and infancy may help to reduce New Zealand’s high childhood allergy rate.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.